Spots Global Cancer Trial Database for recurrent malignant mesothelioma
Every month we try and update this database with for recurrent malignant mesothelioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery | NCT00005636 | Malignant Mesot... | cisplatin pemetrexed diso... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma | NCT00398138 | Leukemia Lung Cancer Malignant Mesot... Myelodysplastic... Primary Periton... | WT-1 analog pep... incomplete Freu... sargramostim polymerase chai... flow cytometry immunoenzyme te... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors | NCT00066651 | Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton... | SS1(dsFv)-PE38 ... | 18 Years - | National Cancer Institute (NCI) | |
| Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma | NCT00458913 | Malignant Mesot... | bortezomib cisplatin | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma | NCT01105390 | Advanced Malign... Epithelial Meso... Recurrent Malig... Sarcomatous Mes... | rilotumumab cisplatin pemetrexed diso... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma | NCT00392444 | Advanced Malign... Recurrent Malig... | sunitinib malat... | 18 Years - | National Cancer Institute (NCI) | |
| Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body | NCT01325753 | Advanced Malign... Extensive Stage... Lung Metastases Recurrent Malig... Recurrent Non-s... Recurrent Small... Stage IV Non-sm... | cryotherapy quality-of-life... | 18 Years - | Wake Forest University Health Sciences | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | NCT01126346 | Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi... | HIPEC Orientati... Consultation wi... Questionnaires | - | Wake Forest University Health Sciences | |
| Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma | NCT00398138 | Leukemia Lung Cancer Malignant Mesot... Myelodysplastic... Primary Periton... | WT-1 analog pep... incomplete Freu... sargramostim polymerase chai... flow cytometry immunoenzyme te... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery | NCT00541073 | Malignant Mesot... | vitamin B12 cisplatin pemetrexed diso... gene expression... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma | NCT01861301 | Epithelioid Mes... Recurrent Malig... Sarcomatoid Mes... Stage II Pleura... Stage III Pleur... Stage IV Pleura... | Laboratory Biom... Tivantinib | 18 Years - | National Cancer Institute (NCI) | |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | NCT01126346 | Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi... | HIPEC Orientati... Consultation wi... Questionnaires | - | Wake Forest University Health Sciences | |
| Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | NCT00227630 | Malignant Mesot... | cisplatin pemetrexed diso... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Gefitinib in Treating Patients With Malignant Mesothelioma | NCT00025207 | Advanced Malign... Epithelial Meso... Recurrent Malig... Sarcomatous Mes... | gefitinib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | NCT00002608 | Adrenocortical ... Brain and Centr... Head and Neck C... Liver Cancer Malignant Mesot... Pheochromocytom... Sarcoma | cisplatin doxorubicin hyd... tamoxifen citra... conventional su... radiation thera... | - 65 Years | National Cancer Institute (NCI) | |
| Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107 | NCT00898547 | Malignant Mesot... | immunoenzyme te... laboratory biom... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma | NCT00054002 | Malignant Mesot... | adjuvant therap... conventional su... porfimer sodium | 18 Years - | Roswell Park Cancer Institute | |
| Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma | NCT00101283 | Mesothelioma | pemetrexed diso... gemcitabine hyd... carboplatin | 18 Years - | Eastern Cooperative Oncology Group | |
| Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer | NCT00024271 | Malignant Mesot... | recombinant int... cisplatin doxorubicin hyd... gemcitabine hyd... mitomycin C conventional su... hyperthermia tr... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Bortezomib in Treating Patients With Malignant Pleural Mesothelioma | NCT00513877 | Malignant Mesot... | bortezomib quality-of-life... | 18 Years - | Cancer Trials Ireland | |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | NCT01126346 | Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi... | HIPEC Orientati... Consultation wi... Questionnaires | - | Wake Forest University Health Sciences | |
| Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed | NCT00004254 | Malignant Mesot... | raltitrexed | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer | NCT00024076 | Lung Cancer Malignant Mesot... Metastatic Canc... Thymoma and Thy... | radiofrequency ... | - | Jonsson Comprehensive Cancer Center | |
| Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery | NCT00005636 | Malignant Mesot... | cisplatin pemetrexed diso... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients | NCT04213794 | Malignant Abdom... Malignant Pelvi... Recurrent Colon... Recurrent Desmo... Recurrent Fallo... Recurrent Gastr... Recurrent Lipos... Recurrent Malig... Recurrent Ovari... Recurrent Prima... Recurrent Recta... Recurrent Rhabd... Recurrent Sarco... Refractory Colo... Refractory Desm... Refractory Fall... Refractory Gast... Refractory Lipo... Refractory Mali... Refractory Ovar... Refractory Prim... Refractory Rect... Refractory Rhab... Refractory Sarc... Resectable Lipo... Resectable Mali... Resectable Sarc... | Cisplatin Cytoreductive S... Doxorubicin Hyperthermic In... Sodium Thiosulf... Computed Tomogr... Magnetic Resona... Positron Emissi... Biospecimen Col... | 1 Year - 25 Years | Mayo Clinic | |
| Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura | NCT00019825 | Esophageal Canc... Lung Cancer Malignant Mesot... Metastatic Canc... | decitabine | 18 Years - | National Cancer Institute (NCI) | |
| Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura | NCT00004920 | Malignant Mesot... | cisplatin raltitrexed | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Immunotoxin Therapy in Treating Patients With Advanced Cancer | NCT00006981 | Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton... | SS1(dsFv)-PE38 ... | 18 Years - | National Cancer Institute (NCI) | |
| High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma | NCT00002465 | Breast Cancer Endometrial Can... Malignant Mesot... | megestrol aceta... | 18 Years - | National Cancer Institute (NCI) | |
| S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery | NCT00770120 | Malignant Mesot... | everolimus | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma | NCT00398138 | Leukemia Lung Cancer Malignant Mesot... Myelodysplastic... Primary Periton... | WT-1 analog pep... incomplete Freu... sargramostim polymerase chai... flow cytometry immunoenzyme te... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma | NCT00003508 | Malignant Mesot... | Antineoplaston ... | 1 Year - 120 Years | Burzynski Research Institute | |
| Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma | NCT01503177 | Recurrent Malig... Stage IA Malign... Stage IB Malign... Stage II Malign... Stage III Malig... Stage IV Malign... | oncolytic measl... laboratory biom... single photon e... computed tomogr... | 18 Years - | Mayo Clinic | |
| S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery | NCT00243074 | Advanced Malign... Epithelial Meso... Recurrent Malig... Sarcomatous Mes... | cediranib malea... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma | NCT01861301 | Epithelioid Mes... Recurrent Malig... Sarcomatoid Mes... Stage II Pleura... Stage III Pleur... Stage IV Pleura... | Laboratory Biom... Tivantinib | 18 Years - | National Cancer Institute (NCI) | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery | NCT00309946 | Advanced Malign... Epithelial Meso... Localized Malig... Recurrent Malig... Sarcomatous Mes... | cediranib malea... | 18 Years - | National Cancer Institute (NCI) | |
| Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma | NCT00821860 | Malignant Mesot... Metastatic Canc... | talc therapeutic tho... therapeutic vid... | 18 Years - | Papworth Hospital NHS Foundation Trust | |
| Capecitabine in Treating Patients With Malignant Mesothelioma | NCT00004183 | Malignant Mesot... | capecitabine | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung | NCT00039182 | Advanced Malign... Epithelial Meso... Recurrent Malig... Sarcomatous Mes... | erlotinib hydro... laboratory biom... | - | National Cancer Institute (NCI) | |
| Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma | NCT00003508 | Malignant Mesot... | Antineoplaston ... | 1 Year - 120 Years | Burzynski Research Institute | |
| Pazopanib in Treating Patients With Malignant Pleural Mesothelioma | NCT00459862 | Advanced Malign... Localized Malig... Recurrent Malig... | laboratory biom... pazopanib hydro... | 18 Years - | National Cancer Institute (NCI) | |
| Immunotoxin Therapy in Treating Patients With Advanced Cancer | NCT00006981 | Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton... | SS1(dsFv)-PE38 ... | 18 Years - | National Cancer Institute (NCI) | |
| PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery | NCT00365053 | Advanced Malign... Epithelial Meso... Recurrent Malig... Sarcomatous Mes... | belinostat laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer | NCT00028782 | Advanced Malign... Localized Malig... Malignant Ascit... Primary Periton... Recurrent Malig... | etanidazole therapeutic con... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma | NCT00027703 | Advanced Malign... Epithelial Meso... Localized Malig... Recurrent Malig... Sarcomatous Mes... | gemcitabine hyd... cisplatin bevacizumab placebo laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients | NCT04213794 | Malignant Abdom... Malignant Pelvi... Recurrent Colon... Recurrent Desmo... Recurrent Fallo... Recurrent Gastr... Recurrent Lipos... Recurrent Malig... Recurrent Ovari... Recurrent Prima... Recurrent Recta... Recurrent Rhabd... Recurrent Sarco... Refractory Colo... Refractory Desm... Refractory Fall... Refractory Gast... Refractory Lipo... Refractory Mali... Refractory Ovar... Refractory Prim... Refractory Rect... Refractory Rhab... Refractory Sarc... Resectable Lipo... Resectable Mali... Resectable Sarc... | Cisplatin Cytoreductive S... Doxorubicin Hyperthermic In... Sodium Thiosulf... Computed Tomogr... Magnetic Resona... Positron Emissi... Biospecimen Col... | 1 Year - 25 Years | Mayo Clinic | |
| Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma | NCT00458913 | Malignant Mesot... | bortezomib cisplatin | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura | NCT00019825 | Esophageal Canc... Lung Cancer Malignant Mesot... Metastatic Canc... | decitabine | 18 Years - | National Cancer Institute (NCI) | |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | NCT00030498 | Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Diffuse A... Adult Ependymob... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Pilocytic... Adult Primary H... Adult Subependy... Advanced Adult ... Advanced Malign... Male Breast Can... Recurrent Adeno... Recurrent Adult... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Esoph... Recurrent Esthe... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Malig... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage II Esopha... Stage II Pancre... Stage III Esoph... Stage III Pancr... Stage IIIB Non-... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Bladde... Stage IV Breast... Stage IV Colon ... Stage IV Esopha... Stage IV Esthes... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Unspecified Adu... Untreated Metas... | erlotinib hydro... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions | NCT00066404 | Cancer | recombinant ade... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed | NCT00004254 | Malignant Mesot... | raltitrexed | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma | NCT00392444 | Advanced Malign... Recurrent Malig... | sunitinib malat... | 18 Years - | National Cancer Institute (NCI) | |
| Bortezomib in Treating Patients With Malignant Pleural Mesothelioma | NCT00513877 | Malignant Mesot... | bortezomib quality-of-life... | 18 Years - | Cancer Trials Ireland | |
| Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery | NCT00309946 | Advanced Malign... Epithelial Meso... Localized Malig... Recurrent Malig... Sarcomatous Mes... | cediranib malea... | 18 Years - | National Cancer Institute (NCI) | |
| PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer | NCT00055705 | Cancer | PV701 | 18 Years - | National Cancer Institute (NCI) | |
| Alanosine in Treating Patients With Cancer | NCT00062283 | Lung Cancer Malignant Mesot... Pancreatic Canc... Sarcoma | L-alanosine | 13 Years - | National Cancer Institute (NCI) | |
| Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. | NCT00107432 | Epithelial Meso... Recurrent Malig... Sarcomatous Mes... Stage IA Malign... Stage IB Malign... Stage II Malign... Stage III Malig... Stage IV Malign... | sorafenib tosyl... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions | NCT00066404 | Cancer | recombinant ade... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma | NCT01064648 | Epithelioid Mes... Pleural Maligna... Recurrent Malig... Sarcomatoid Mes... | Cediranib Malea... Cisplatin Laboratory Biom... Pemetrexed Diso... Placebo Adminis... | 18 Years - | National Cancer Institute (NCI) | |
| Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma | NCT01861301 | Epithelioid Mes... Recurrent Malig... Sarcomatoid Mes... Stage II Pleura... Stage III Pleur... Stage IV Pleura... | Laboratory Biom... Tivantinib | 18 Years - | National Cancer Institute (NCI) | |
| Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma | NCT00030459 | Malignant Mesot... | cisplatin mitomycin C vinblastine sul... vinorelbine tar... | - | National Cancer Institute (NCI) | |
| Pazopanib in Treating Patients With Malignant Pleural Mesothelioma | NCT00459862 | Advanced Malign... Localized Malig... Recurrent Malig... | laboratory biom... pazopanib hydro... | 18 Years - | National Cancer Institute (NCI) | |
| AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma | NCT01105390 | Advanced Malign... Epithelial Meso... Recurrent Malig... Sarcomatous Mes... | rilotumumab cisplatin pemetrexed diso... laboratory biom... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
